MedTrace Logo

A Multiple Case Study of Schema Therapy for Difficult-to-treat Depression- DEPRE-ST*Case

NCT06655623 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 2

Last updated 2026-04-17

No results posted yet for this study

Summary

This clinical multiple case study seeks to expand the knowledge of how schema therapy could function as an intervention for difficult-to-treat depression. The study will explore in depth the course of a 30 session treatment with schema therapy conducted over approximately one year on three individual patients at two different psychiatric treatment sites.

Together, the data from this study will inform about the feasibility of schema therapy for difficult-to-treat depression as well as form the base for recommendations in adapting schema therapy for this particular patient group.

Conditions

Interventions

BEHAVIORAL

Schema therapy

Schema therapy is a form of psychotherapy invented to address more complex clinical cases. It consists of elements from Cognitive Behavioral Therapy as well as psychodynamic, emotion-focused and gestalt therapies, with a distinct focus on experiential interventions. A therapy manual was developed for use in this study.

Sponsors & Collaborators

  • Mental Health Centre Copenhagen, Bispebjerg and Frederiksberg Hospital

    collaborator OTHER

  • Region of Southern Denmark

    lead OTHER

Principal Investigators

  • Stine B. Moeller, PhD · Region of Southern Denmark Psychiatry; University of Southern Denmark

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-11-06
Primary Completion
2026-02-20
Completion
2026-02-26

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06655623 on ClinicalTrials.gov